EconPapers    
Economics at your fingertips  
 

The lipoprotein-associated phospholipase A2 inhibitor Darapladib sensitises cancer cells to ferroptosis by remodelling lipid metabolism

Mihee Oh, Seo Young Jang, Ji-Yoon Lee, Jong Woo Kim, Youngae Jung, Jiwoo Kim, Jinho Seo, Tae-Su Han, Eunji Jang, Hye Young Son, Dain Kim, Min Wook Kim, Jin-Sung Park, Kwon-Ho Song, Kyoung-Jin Oh, Won Kon Kim, Kwang-Hee Bae, Yong-Min Huh, Soon Ha Kim, Doyoun Kim, Baek-Soo Han (), Sang Chul Lee (), Geum-Sook Hwang () and Eun-Woo Lee ()
Additional contact information
Mihee Oh: Korea Research Institute of Bioscience and Biotechnology (KRIBB)
Seo Young Jang: Western Seoul Center, Korea Basic Science Institute
Ji-Yoon Lee: Korea Research Institute of Bioscience and Biotechnology (KRIBB)
Jong Woo Kim: Korea Research Institute of Bioscience and Biotechnology (KRIBB)
Youngae Jung: Western Seoul Center, Korea Basic Science Institute
Jiwoo Kim: Drug Discovery Platform Research Center, Korea Research Institute of Chemical Technology (KRICT)
Jinho Seo: Korea Research Institute of Bioscience and Biotechnology (KRIBB)
Tae-Su Han: Korea Research Institute of Bioscience and Biotechnology (KRIBB)
Eunji Jang: Novomics Co., Ltd.
Hye Young Son: YUHS-KRIBB Medical Convergence Research Institute
Dain Kim: Western Seoul Center, Korea Basic Science Institute
Min Wook Kim: Korea Research Institute of Bioscience and Biotechnology (KRIBB)
Jin-Sung Park: MitoImmune Therapeutics Inc.
Kwon-Ho Song: Daegu Catholic University School of Medicine
Kyoung-Jin Oh: Korea Research Institute of Bioscience and Biotechnology (KRIBB)
Won Kon Kim: Korea Research Institute of Bioscience and Biotechnology (KRIBB)
Kwang-Hee Bae: Korea Research Institute of Bioscience and Biotechnology (KRIBB)
Yong-Min Huh: Novomics Co., Ltd.
Soon Ha Kim: MitoImmune Therapeutics Inc.
Doyoun Kim: Drug Discovery Platform Research Center, Korea Research Institute of Chemical Technology (KRICT)
Baek-Soo Han: Korea Research Institute of Bioscience and Biotechnology (KRIBB)
Sang Chul Lee: Korea Research Institute of Bioscience and Biotechnology (KRIBB)
Geum-Sook Hwang: Western Seoul Center, Korea Basic Science Institute
Eun-Woo Lee: Korea Research Institute of Bioscience and Biotechnology (KRIBB)

Nature Communications, 2023, vol. 14, issue 1, 1-17

Abstract: Abstract Arachidonic and adrenic acids in the membrane play key roles in ferroptosis. Here, we reveal that lipoprotein-associated phospholipase A2 (Lp-PLA2) controls intracellular phospholipid metabolism and contributes to ferroptosis resistance. A metabolic drug screen reveals that darapladib, an inhibitor of Lp-PLA2, synergistically induces ferroptosis in the presence of GPX4 inhibitors. We show that darapladib is able to enhance ferroptosis under lipoprotein-deficient or serum-free conditions. Furthermore, we find that Lp-PLA2 is located in the membrane and cytoplasm and suppresses ferroptosis, suggesting a critical role for intracellular Lp-PLA2. Lipidomic analyses show that darapladib treatment or deletion of PLA2G7, which encodes Lp-PLA2, generally enriches phosphatidylethanolamine species and reduces lysophosphatidylethanolamine species. Moreover, combination treatment of darapladib with the GPX4 inhibitor PACMA31 efficiently inhibits tumour growth in a xenograft model. Our study suggests that inhibition of Lp-PLA2 is a potential therapeutic strategy to enhance ferroptosis in cancer treatment.

Date: 2023
References: View references in EconPapers View complete reference list from CitEc
Citations: View citations in EconPapers (1)

Downloads: (external link)
https://www.nature.com/articles/s41467-023-41462-9 Abstract (text/html)

Related works:
This item may be available elsewhere in EconPapers: Search for items with the same title.

Export reference: BibTeX RIS (EndNote, ProCite, RefMan) HTML/Text

Persistent link: https://EconPapers.repec.org/RePEc:nat:natcom:v:14:y:2023:i:1:d:10.1038_s41467-023-41462-9

Ordering information: This journal article can be ordered from
https://www.nature.com/ncomms/

DOI: 10.1038/s41467-023-41462-9

Access Statistics for this article

Nature Communications is currently edited by Nathalie Le Bot, Enda Bergin and Fiona Gillespie

More articles in Nature Communications from Nature
Bibliographic data for series maintained by Sonal Shukla () and Springer Nature Abstracting and Indexing ().

 
Page updated 2025-03-22
Handle: RePEc:nat:natcom:v:14:y:2023:i:1:d:10.1038_s41467-023-41462-9